Result of AGM

RNS Number : 9798B

Venture Life Group PLC

22 June 2016

 

Venture Life Group plc

("Venture Life" or "the Group")

Result of AGM

Bracknell, UK - 22 June 2016: Venture Life Group plc (AIM: VLG), the international consumer self-care group focused on developing, manufacturing and commercialising products for the ageing population, announces that at its Annual General Meeting held earlier today all resolutions were duly passed.

The Group will be issuing a pre-close trading statement for the first half of the financial year ending 31 December 2016 towards the end of July 2016.

- Ends -

For further information please contact:

Venture Life Group PLC

Jerry Randall, Chief Executive Officer                                                                    [phone]

James Hunter, Chief Financial Officer                                                   

Panmure Gordon (UK) Limited (Nominated Adviser and Broker)                             
Freddy Crossley                                                                                                               [phone]

Peter Steel

Duncan Monteith                                                                                                           
Corporate Finance

Tom Salvesen
Corporate Broking                                                                               

Square1 Consulting

David Bick                                                                                                                          [phone]

Brian Alexander                                                                                                              

About Venture Life

Venture Life is an international consumer self-care company focused on developing, manufacturing and commercialising products for the ageing population. The Group's product range and pipeline currently includes the UltraDEX oral care products range, food supplements for lowering cholesterol and maintaining brain function, dermo-cosmetics for addressing the signs of ageing, and medical devices for improving minor aches and pains, dry eyes and itchy skin.

The products, which typically are recommended by pharmacists or healthcare practitioners, are available primarily through pharmacies supplied by the Group's international distribution partners.

Through its manufacturing company, Biokosmes, the Group also provides development and manufacturing services to companies in the medical devices and cosmetic sectors.

 

END

 

 

RAGUUUARNWANUAR